行情

NOVN

NOVN

Novan
NASDAQ

实时行情|Nasdaq Last Sale

2.700
-0.060
-2.17%
交易中 14:53 09/20 EDT
开盘
2.750
昨收
2.760
最高
2.920
最低
2.700
成交量
2.53万
成交额
--
52周最高
3.240
52周最低
0.6500
市值
7,038.83万
市盈率(TTM)
-2.8148
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NOVN 新闻

  • 美国银行:亚马逊电动货车车队是一项明智的长期投资
  • 新浪美股.1小时前
  • 美联储宣布回购协议操作计划 确保季度末市场平稳
  • 新浪美股.1小时前
  • 法国兴业银行计划在其法国零售部门裁员530人
  • 新浪美股.1小时前
  • 库克现身发售现场 消费者购买新款iPhone意愿超预期
  • 新浪美股.2小时前

更多

所属板块

制药
+1.26%
制药与医学研究
+1.12%

热门股票

名称
价格
涨跌幅

NOVN 简况

Novan, Inc. is a clinical development-stage biotechnology company. The Company is focused on leveraging nitric oxide’s naturally occurring anti-microbial and immunomodulatory mechanisms of action to treat a range of diseases. The Company has created a Nitricil technology platform enabling the development of new chemical entities (NCEs) with delivery of nitric oxide. The Company’s two key components of its nitric oxide platform are its Nitricil technology, which drives the creation of NCEs, and its formulation science, both of which it uses to tune its product candidates for specific indications. Novan’s Nitricil technology enables it to store large amounts of nitric oxide gas in a stable, solid form by chemically loading it on a macromolecule, or polymer. The nitric oxide platform has produced a portfolio that includes the various clinical stage dermatology product candidates: SB204, SB206, SB208 and SB414.
展开

Webull提供Novan Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。